Chunhui Han, Ph.D.

(877) 460-4673
Chunhui Han, Ph.D.
Therapeutic Medical Physicist
Clinical Expertise
  • Radiation Physics
Other Languages Spoken
Mandarin
Academic Appointments
  • Clinical Professor, Department of Radiation Oncology
As a medical physicist, Chunhui Han, Ph.D., works hand-in-hand with our radiation oncologists to ensure that each radiation treatment is scrupulously calibrated, meets the most exacting standards and provides maximum benefit to patients while minimizing side effects.
 
A gifted scientist with degrees in particle physics, computer science and engineering, Dr. Han has been with City of Hope for more than a decade, training radiation professionals and maintaining quality control protocols for a wide variety of radiation treatment systems.
 
After undergraduate studies at Beijing University in China, Dr. Han received his master’s degree and Ph.D. at the University of Michigan in Ann Arbor. He considers City of Hope an ideal environment where his work impacts patients' lives daily, and he has the freedom to choose his area of research “to achieve professional and personal growth.”
 

Location

Education & Experience

Board Certifications

  • 2009, Diplomate of American Board of Radiology in Therapeutic Radiologic Physics

Degrees

  • 2003, Ph.D., Experimental Elementary Particle Physics, University of Michigan, Ann Arbor, MI
  • 2002, M.Sc., Computer Science and Engineering, University of Michigan, Ann Arbor, MI
  • 1998, Bachelor of Science, Physics, Peking University, Beijing, China (cum laude)

Fellowship

  • 2004-2006, Medical Physics, Department of Radiation Oncology, City of Hope, Duarte, CA
  • 2004, Nuclear Physics, Center for Experimental Physics and Astrophysics, University of Washington, Seattle, WA

Professional Experience

  • 2024-present, Clinical professor, Department of Radiation Oncology, City of Hope, Duarte, CA
  • 2014-2024, Associate clinical professor, Department of Radiation Oncology, City of Hope, Duarte, CA
  • 2006-present, Therapeutic medical physicist, Department of Radiation Oncology, City of Hope, Duarte, CA
  • 2004-2006, Postdoctoral research associate in Medical Physics, Department of Radiation Oncology, City of Hope, Duarte, CA
  • 2004, Postdoctoral research associate in Nuclear Physics, Center for Experimental Physics and Astrophysics, University of Washington, Seattle, WA

Awards & Memberships

Memberships

  • Member of American Association of Physicists in Medicine
  • Member of American Society for Therapeutic Radiology and Oncology
  • Member of American Physical Society
  • Member of AAPM Southern California Chapter
  • Member of North American Chinese Medical Physicists Association

Publications

  • Variations of target volume definition and daily target localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression. Chunhui Han, Sagus Sampath, Timothy E. Schultheis, Jeffrey Y.C. Wong Medical Dosimetry 2017;42:116-121.10.1016/j.meddos.2017.01.008
  • Estimation of Radiation-induced Secondary Cancer Risks for Early-stage Non-Small-Cell Lung Cancer Patients after Stereotactic Body Radiotherapy. Chunhui Han, Ph.D., Timothy E  Schultheiss, Ph.D., Jeffrey YC Wong, M.D. Practical Radiation Oncology 2017;7:e185-194.10.1016/j.prro.2016.10.009
  • Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation. Chunhui Han, Timothy E Schultheiss, Jeffrey Y.C. Wong Radiotherapy and Oncology 2012;102:315-320.
  • Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer. Chunhui Han, Daniel A Schiffner, Timothy E Schultheiss, et al. Radiotherapy and Oncology 2012;102:309-314.
  • Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy. Chunhui Han, Yi-Jen Chen, An Liu, Timothy E. Schultheiss, Jeffrey Y.C. Wong International Journal of Radiation Oncology, Biology, Physics 2008;70:1256-1262.
  • Dosimetry study and in-vivo dose verification of conformal avoidance treatment of anal adenocarcinoma using helical tomotherapy. Chunhui Han, Yi-Jen Chen, An Liu, Timothy E. Schultheiss, Jeffrey Y.C. Wong Medical Dosimetry 2007;32(1):33-37.
  • Setup Variations in Radiotherapy of Esophageal Cancer: Evaluation by Daily MVCT Localization. Yi-Jen Chen, Chunhui Han, Timothy E. Schultheiss, Kemp H. Kernstine, Stephen Shibata, Nayana Vora, Richard D. Pezner, Jeffrey Y.C. Wong International Journal of Radiation Oncology, Biology, Physics 2007;68:1537-1545.
  • Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan. Yi-Jen Chen, An Liu, Chunhui Han et al. Medical Dosimetry 2007;32:166-171.
  • Measurement of the isolated photon cross section in pbarp collisions at sqrt(s) = 1.96TeV VM Abazov, B Abbott, M Abolins, et al. Phys. Lett. B 639, 151-158 (2006) (Impact Factor: 4.569. Times cited: 54)
  • Search for the Higgs Boson in H->WW(*) Decays in pbarp Collisions at sqrt(s) =1.96 TeV. VM Abazov, B Abbott, M Abolins, et al. Phys. Rev. Lett. 96, 011801 (2006) (Impact Factor: 7.943. Times cited: 22)
  • The Upgraded D0 Detector. VM Abazov, B Abbott, M Abolins, et al. Nucl. Instr. and Methods in Phys Res A 565, 463-537 (2006) (Impact Factor: 1.077. Times cited: 397) 4. Measurement of the lifetime difference in the Bs system. VM Abazov, B Abbott, M Abolins, et al. Phys. Rev. Lett. 95, 171803 (2005) (Impact Factor: 7.943. Times cited: 12)
  • Measurement of semileptonic branching fractions of B mesons to narrow D** states. VM Abazov, B Abbott, M Abolins, et al. Phys. Rev. Lett. 95, 171801 (2005) (Impact Factor: 7.943. Times cited: 11)
  • Search for large extra spatial dimensions in dimuon production at Dzero. VM Abazov, B Abbott, M Abolins, et al. Phys. Rev. Lett. 95, 161602 (2005) (Impact Factor: 7.943. Times cited: 23)
  • Search for supersymmetry via associated production of charginos and neutralinos in final states with three leptons. VM Abazov, B Abbott, M Abolins, et al.
    Phys. Rev. Lett. 95, 151805 (2005) (Impact Factor: 7.943. Times cited: 18)
  • Search for neutral supersymmetric Higgs bosons in multojet events at sqrt(s)=1.96 TeV. VM Abazov, B Abbott, M Abolins, et al. Phys. Rev. Lett. 95, 151801 (2005) (Impact Factor: 7.943. Times cited: 63)